Obalon Therapeutics, Inc. Announces Two Agreements To Provide Up To $30 Million of Capital
27 déc. 2018 17h53 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces FDA Approval of Obalon Navigation System
21 déc. 2018 09h00 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Key Weight Loss and Safety Data Presented for the Obalon Swallowable Gas-Filled Balloon System at the 35th ASMBS Annual Meeting at Obesity Week 2018
15 nov. 2018 09h15 HE
|
Obalon Therapeutics, Inc.
Clinical results presented from over 1,300 patients treated at 108 sites with Obalon’s non-surgical weight loss solution in commercial setting SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Obalon...
Obalon Balloon System Data to be Featured in Presentation During 35th ASMBS Annual Meeting at Obesity Week 2018
07 nov. 2018 09h15 HE
|
Obalon Therapeutics, Inc.
Clinical results from over 1,300 patients at 108 sites treated with Obalon’s novel weight loss device solution in commercial use SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics,...
Obalon Announces Third Quarter 2018 Financial Results
02 nov. 2018 08h01 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
FDA Grants PMA-S Approval for Obalon Touch™ Inflation System
26 sept. 2018 09h02 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon to Host Corporate Strategy Update Call with Investors and Analysts on September 10, 2018
29 août 2018 09h01 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics to Raise $10 Million in Private Placement
23 août 2018 09h02 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Upcoming Conference Presentation
07 août 2018 09h02 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Schedules First Quarter 2018 Financial Results Conference Call for May 10, 2018 at 5:00 p.m. Eastern Time
04 mai 2018 10h01 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...